A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Biomedical Research


MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation

   by Lucy Shaw    107
MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation

MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease.

Chemspace collaborates with ChemAlive

   by Kateryna Shtereverya    318
Chemspace collaborates  with ChemAlive

Chemspace and ChemAlive (the largest repository of quantum chemical data, a Contract Research Company that develops software products to obtain accurate and reliable data on molecular properties, synthetic reactions, verification of molecules using quantum chemistry), announced the launch of the collaboration to provide accurate molecular structural information about commercial small molecules.

11 Inspiring Women Advancing Artificial Intelligence In Life Sciences

   by BiopharmaTrend    4039
11 Inspiring Women Advancing Artificial Intelligence In Life Sciences

In this post, we decided to highlight eleven entrepreneurial women, leading the way in applying advanced computational technologies, such as machine learning (ML), deep learning (DL), and other artificial intelligence (AI) components, for tackling some of the hardest challenges of science -- in drug discovery and healthcare. This list is composed in alphabetical order. 

Tzager - A Smart AI Agent For Biomedical Research

   by Nikos Tzagarakis    1248
Tzager - A Smart AI Agent For Biomedical Research

Tzager is an A.I. agent built for biomedicine research, drug discovery and personalized medicine, with the main features being Biochemical Analysis, Predictor Research/Models and Literature Review/Management. The difference with Tzager is that it is not just another deep learning algorithm trained to solve very specific problems, but the intelligence system with its own framework based on Causal Equations and Bayesian Networks.

2nd Annual Bispecifics in Discovery & Development Congress

   by BiopharmaTrend    444
2nd Annual Bispecifics in Discovery & Development Congress

Oxford Global’s 2nd Annual Bispecifics in Discovery & Development Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.

New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.